CAS: 1111-97-3; 3-Chloro-3-Methylbut-1-Yne

该化合物是具有分子式C5H7Cl的卤化烷基(卤化烷基),该化合物的特点是终端烷基化合物和反应氯替代物,它具有三级碳的活性替代体,使它成为有机合成的多用途中间体,其结构能够参与核生殖替代,消除和混合反应,便利复杂分子的制备.该化合物在制药和农用化学研究中特别有用,用于建造功能化的烷基和异体循环.在受控条件下和高纯度的稳定性使其适合精确应用.由于其易燃性和潜在的再活动,需要适当处理.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号115-19-5 3-甲基丁炔醇-3 | CAS号36566-81-1 3-hydroperoxy-3... | CAS号598-23-2 3-甲基-1-丁炔 | CAS号108176-11-0 1-chloro-3,3-di... | CAS号78-80-8 2-甲基-1-丁烯-3-炔 | CAS号104654-88-8 3,3-dimethyl-2-... | CAS号523-64-8 FLINDERSINE | CAS号103805-58-9 6-[(E)-2-(3,5-d... | CAS号14882-94-1 芸香内酯 | CAS号14465-32-8 4-Chloro-N-(1,1... | CAS号2085-66-7 叔戊基叔丁基胺 | CAS号2109-84-4 1-(2-methylbut-... | CAS号21316-80-3 7-hydroxy-3-(2-... | CAS号21421-66-9 5,7-dimethoxy-2... | CAS号17166-43-7 dimethyl (3-met...

合成工艺路线路线简述

  • 合成目标产物 3-Chloro-3-Methyl-1-Butyne 主要起始原料 3-Methyl Butynol
  • (文献来源)合成步骤主要原料 3-Methyl Butynol
2-甲基-3-丁炔-2-醇置于盐酸体系中,化学反应 3.0H,以25%的收率获得3-氯-3-甲基-1-丁炔
参考文献:的全合成塞科-Lateriflorone
标题:的全合成塞科-Lateriflorone
摘要:描述了一种趋向于合成lateiflorone(5)的策略.我们的方法是基于生物合成的考虑,并利用一系列的异戊烯化,氧化和克莱森反应来构建亚甲基苯醌6,以及串联的克莱森/狄尔斯-阿尔德反应级联反应来合成笼型三轮车7.片段的联盟6和7导致的合成开环-Lateriflorone(49).
Doi:10.1016/s0040-4020(03)00862-7

海关参考信息

专利信息


专利号:US-6504041-B2
优先权日:1996-11-15
标题 :Synthesis of ruthenium or osmium metathesis catalysts
发明人:GRUBBS ROBERT H; BELDERRAIN TOMAS R; BROWN SETH N; WILHELM THOMAS E
权利人:CALIFORNIA INST OF TECHN
摘要:The present invention relates to the synthesis of highly active ruthenium and osmium carbene metathesis catalyst in good yield from readily available starting materials. The catalysts that may be synthesized are of the general formula n wherein: n M is ruthenium or osmium; n X and X 1 are independently any anionic ligand; n L and L 1 are any neutral electron donor ligand; and, n R and R 1 are each hydrogen or one of the following substituent groups: C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, C 1 -C 20 alkyl, aryl, C 1 -C 20 carboxylate, C 1 -C 20 alkoxy, C 2 -C 20 alkenyloxy, C 2 -C 20 alkynyloxy, aryloxy, C 2 -C 20 alkoxycarbonyl, C 1 -C 20 alkylthio, C 1 -C 20 alkylsulfonyl and C 1 -C 20 alkylsulfinyl. Optionally, the substituent group may be substituted with one or more groups selected from C 1 -C 5 alkyl, halogen, C 1 -C 5 alkoxy, and aryl. When the substitute aryl group is phenyl, it may be further substituted with one or more groups selected from a halogen, a C 1 -C 5 alkyl, or a C 1 -C 5 alkoxy. Specific synthetic protocols for vinyl alkylidene catalysts wherein R is hydrogen and R 1 is —CHCR 12 R 13 and non-vinyl alkylidene catalysts are also disclosed. In addition to the ease of synthesis (typically a one-step synthesis), the reactions generally may be run at or above room temperature and the resulting products usually may be used without extensive post synthesis purification.

专利号:US-6613910-B2
优先权日:2001-04-02
标题 :One-pot synthesis of group 8 transition metal carbene complexes useful as olefin metathesis catalysts
发明人:GRUBBS ROBERT H; MORGAN JOHN P; BENITEZ DIEGO; LOUIE JANIS
权利人:CALIFORNIA INST OF TECHN
摘要:The invention provides a novel method for synthesizing transition metal carbene complexes useful as olefin metathesis catalysts. The method is a convenient one-pot synthesis in which transition metal carbenes are prepared in high yield from readily available starting materials via a dihydrogen complex containing two different anionic ligands, preferably a phosphine and a heteroatom-stabilized carbene. The invention additionally provides a method for synthesizing precursors to carbene ligands useful, inter alia, in the aforementioned one-pot synthesis. The precursors are in the form of trichloromethyl adducts of the formula L 1 -CCl 3 , where L 1 is a heteroatom-stabilized carbene ligand, and are prepared by contacting an unsaturated, ionized analog of L-CCl 3 with a non-nucleophilic base in the presence of chloroform.

专利号:US-2010137421-A1
优先权日:2006-11-08
标题 :Small molecule therapeutics, synthesis of analogues and derivatives and methods of use
发明人:THEODORAKIS EMMANUEL; BATOVA AYSE
权利人:THEODORAKIS EMMANUEL; BATOVA AYSE
摘要:Provided herein are compounds that are inducers of apoptosis activators of caspases and pharmaceutically acceptable derivatives thereof. Also provided are methods of synthesis of the compounds and methods for treatment of diseases in which there is uncontrolled cell growth and spread of abnormal cells, such as cancers, by administering the compounds.

专利号:US-9403854-B2
优先权日:2001-03-30
标 题 :Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
发明人:GRUBBS ROBERT H; CHATTERJEE ARNAB K; CHOI TAE-LIM; GOLDBERG STEVEN D; LOVE JENNIFER A; MORGAN JOHN P; SANDERS DANIEL P; SCHOLL MATTHIAS; TOSTE F DEAN; TRNKA TINA M
权利人:CALIFORNIA INST OF TECHN
摘要:The invention pertains to the use of Group 8 transition metal carbene complexes as catalysts for olefin cross-metathesis reactions. In particular, ruthenium and osmium alkylidene complexes substituted with an N-heterocyclic carbene ligand are used to catalyze cross-metathesis reactions to provide a variety of substituted and functionalized olefins, including phosphonate-substituted olefins, directly halogenated olefins, 1,1,2-trisubstituted olefins, and quaternary allylic olefins. The invention further provides a method for creating functional diversity using the aforementioned complexes to catalyze cross-metathesis reactions of a first olefinic reactant, which may or may not be substituted with a functional group, with each of a plurality of different olefinic reactants, which may or may not be substituted with functional groups, to give a plurality of structurally distinct olefinic products. The methodology of the invention is also useful in facilitating the stereoselective synthesis of 1,2-disubstituted olefins in the cis configuration.

专利号:US-6313320-B1
优先权日:1999-04-26
标 题:Process for the preparation of calanolide precursors
发明人:FOX MARTIN EDWARD; MEEK GRAHAM ANDREW
权利人:CHIROTECH TECHNOLOGY INC
摘要:The present invention concerns compounds of the formulawherein R1, R2, R3, R4 and R6 each represent H or an organic group of up to 20 C atoms, or any pair of R2 and R3 or R2 and R6 or R4 and R6 forms a cyclic group, and R5SO2 is a cleavable protecting group in which R5 is an organic group of up to 20 C atoms. These compounds are useful as intermediates in the synthesis of calanolide A and related antiviral compounds.

专利号:US-7902196-B2
优先权日:2005-03-17
标 题 :Synthesis of avrainvillamide, strephacidin B, and analogues thereof
发明人:MYERS ANDREW G; HERZON SETH B; WULFF JEREMY EARLE; SIEGRIST ROMAIN; SVENDA JAKUB; ZAJAC MATTHEW ALLEN
权利人:HARVARD COLLEGE
摘要:The syntheses of the natural products, avrainvillamide and stephacidin B, are provided. The α,β-unsaturated nitrone functionality of avrainvillamide and its 3-alkylidene-3H-indole 1-oxide core is shown to covalently and reversibly bond to heteroatom-based nucleophiles. This capability may allow these molecules to bind active site nucleophiles and may provide the basis for designing potent and selective enzyme inhibitors. Both avrainvillamide and its dimer stephacidin B have been reported to exhibit antiproliferative activity, and avrainvillamide has been reported to exhibit antimicrobial activity against multi-drug resistant bacteria. Avrainvillamide has been found to target cytoskeleton-linking membrane protein (CLIMP-63) thereby preventing cells from undergoing mitosis. The invention provides syntheses of these natural products as well as analogs of these natural products and their functional cores. The compounds of the invention may be used in the treatment of diseases such as cancer, autoimmune diseases, and bacterial infection.
武汉弘德悦欣医药科技有限公司
小微企业
信用代码: 91420102MA4K4WB79G法定代表人:袁洪杰
注册资本:180万(元)企业类型:有限责任公司(自然人投资或控股)
成立日期:2019-07-31登记机关:武汉市江岸区市场监督管理局
注册地址: 武汉市江岸区车站路6号怡东大厦19层F室
医药、生物工程、生物制品的技术开发、技术服务;医药中间体、化学助剂及化工产品(不含化学危险品)的销售。(依法须经审批的项目,经相关部门审批后方可开展经营活动)
免费会员展台
http://www.hongdepharma.com
企业联系电话:027-83855396👤
📞 山东昱轩化工产品有限公司
产品销售经理: 吴经理
手机: 13657260109
邮件: 2143879032@qq.com
⚠️ 声明: 咨询或交易时请注意风险评估和信息核实,百琢研不参与任何交易。

地址: 武汉市江岸区车站路6号怡东大厦19层F室
常规和库存产品*产品总量: 509

平台资质认证✓营业执照✓
3-氯-3-甲基-1-丁炔
3-chloro-3-methyl-1-butyne
产品图片纯度:98
250kg/drum
南京恒旺生物医药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.blakechem.com
企业联系电话:025-86199365👤
📞南京恒旺生物医药有限公司 ⚠️参考联系方式
联系人:戎有明
电话:025-86199365
手机:018061201868
传真:025-58742456
邮箱:sales@blakechem.com
通信地址: 江苏省南京市高新技术开发区高科五路5号29幢611室
邮编: 210061
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省南京市高新技术开发区高科五路5号29幢611室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海康拓化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.kangtuochem.com
企业联系电话:021-69185552;69185553;13701777608👤
📞上海康拓化工有限公司 ⚠️参考联系方式
联系人:陈小姐
电话:021-69185552;69185553;13701777608
手机:13701777608
传真:QQ:63651968
邮箱:kangtuochem@163.com
通信地址: 上海市嘉定区 沙河路
邮编: 200000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市嘉定区 沙河路
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
甘肃泰鑫隆新材料有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.txlchem.com
企业联系电话:18061201868👤
📞甘肃泰鑫隆新材料有限公司 ⚠️参考联系方式
联系人:戎有明
电话:18061201868
手机:18061201868
传真:0931-12345678
邮箱:2802108376@qq.com
通信地址: 甘肃省兰州市兰州新区(秦川镇)化工园区
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:甘肃省兰州市兰州新区(秦川镇)化工园区
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: Chavalit Sittisombut, Et Al. Synthesis And Cytotoxic Activity Of Benzo[参考文献]: Soizic Prado, Et Al. Benzofuro[3,2-F][1]Benzopyrans: A New Class Of Antitubercular Agents. Bioorg Med Chem. 2006 Aug 1;14(15):5423-8.

合成参考文献


摘要:Ohno, H.; Tomioka, K., Science of Synthesis, (2008) 44, 127.
摘要:Sano, H.; Nishimura, J., Science of Synthesis, (2010) 45, 485.
摘要:Delvos, L. B.; Oestreich, M., Science of Synthesis Knowledge Updates, (2017) 1, 165.
摘要:Hashmi, A. S. K., Science of Synthesis Knowledge Updates, (2018) 1, 385.
摘要:Murai, T., Science of Synthesis: Knowledge Updates, (2024) 2, 418.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知